Table 4.
Multivariate association of clinical variables with 30-day, 1-year and total mortality in the subgroups of patients with STEMI and NSTEMI
| N=4111 | Mortality, N (%) |
||||||
|---|---|---|---|---|---|---|---|
| STEMI | NSTEMI | 30 days |
1 year |
All |
|||
| 2397 | 1714 | STEMI | NSTEMI | STEMI | NSTEMI | STEMI | NSTEMI |
| Admission demographics | |||||||
| Age (year) | 1.055 (1.033 to 1.077) | 1.073 (1.031 to 1.116) | 1.061 (1.044 to 1.078) | 1.056 (1.035 to 1.079) | 1.077 (1.062 to 1.091) | 1.061 (1.046 to 1.077) | |
| SBP (mm Hg) | 0.988 (0.982 to 0.994) | 0.983 (0.970 to 0.995) | 0.992 (0.987 to 0.997) | 0.988 (0.982 to 0.995) | 0.993 (0.989 to 0.997) | 0.994 (0.990 to 0.998) | |
| Heart rate (beat/min) | 1.008 (1.001 to 1.015) | 1.008 (0.997 to 1.02) | 1.008 (1.002 to 1.013) | 1.007 (1.001 to 1.013) | 1.008 (1.004 to 1.012) | 1.007 (1.002 to 1.011) | |
| eGFR (ml/min) | 0.986 (0.975 to 0.997) | 0.987 (0.969 to 1.005) | 0.982 (0.974 to 0.991) | 0.978 (0.968 to 0.989) | 0.986 (0.979 to 0.993) | 0.987 (0.979 to 0.995) | |
| Admission plasma glucose (mmol/l) | 1.070 (1.034 to 1.107) | 1.074 (1.005 to 1.148) | 1.071 (1.042 to 1.10) | 1.021 (0.979 to 1.066) | 1.076 (1.051 to 1.10) | 1.014 (0.983 to 1.047) | |
| Prior diabetes | 1.035 (0.652 to 1.641) | 0.629 (0.264 to 1.502) | 1.083 (0.772 to 1.518) | 0.878 (0.566 to 1.36) | 1.189 (0.907 to 1.559) | 1.055 (0.773 to 1.44) | |
| Admission treatment (yes vs no) | |||||||
| Loop diuretic | 1.330 (0.890 to 1.989) | 1.66 (0.759 to 3.629) | 1.706 (1.248 (2.333) | 1.988 (1.283 to 3.081) | 1.365 (1.068 to 1.745) | 2.03 (1.496 to 2.756) | |
| Discharge medication (yes vs no) | |||||||
| Aspirin | 0.301 (0.135 to 0.672) | 0.308 (0.088 to 1.076) | 0.499 (0.322 to 0.773) | 0.869 (0.523 to 1.433) | 0.697 (0.501 to 0.970) | 1.052 (0.711 to 1.557) | |
| β-Blocker | 0.208 (0.095 to 0.455) | 0.337 (0.094 to 1.207) | 0.469 (0.320 to 0.687) | 0.77 (0.485 to 1.222) | 0.520 (0.393 to 0.698) | 0.939 (0.674 to 1.308) | |
| Statin | 1.046 (0.375 to 2.918) | 0.255 (0.066 to 0.992) | 0.551 (0.334 to 0.908) | 0.745 (0.449 to 1.237) | 0.615 (0.429 to 0.880) | 0.65 (0.444 to 0.951) | |
| ACE inhibitor or ARB | 0.392 (0.153 to 1.006) | 0.451 (0.121 to 1.673) | 0.903 (0.545 to 1.496) | 0.541 (0.348 to 0.841) | 1.041 (0.712 to 1.523) | 0.857 (0.616 to 1.194) | |
Data are HR (95% CI).
ARB, angiotensin receptor blocker; eGFR, estimated glomerular filtration rate calculated using the MDRD formula; MDRD, modification of diet in renal disease; NSTEMI, non-ST elevation myocardial infarction; SBP, systolic blood pressure; STEMI, ST elevation myocardial infarction.